The Hip Fracture Surgical Approach Trial

NCT ID: NCT06146205

Last Updated: 2025-09-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

406 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-30

Study Completion Date

2028-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The HIFSAT study will compare the standard direct lateral approach to hemiarthroplasty to a new muscle sparing approach (SPAIRE) in femoral neck fracture patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Femoral neck fractures are mostly treated with a hemiarthroplasty, where the fractured femoral head is replaced with a metal implant. The most common surgical approach to hemiarthroplasty has been the lateral approach, in which the gluteus medius tendon is partially released from the greater trochanter. Hip pain and limping is not uncommon after this approach has been used. A new surgical approach (SPAIRE) has been developed to alleviate this problem, and in this method the surgeon approaches the injured hip joint from posterior, preserving most of the muscles and tendons around the hip. This trial is designed to assess if this new SPAIRE approach leads to better results than the lateral approach in patients with femoral neck fractures.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Fracture Femoral Neck Fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Direct lateral approach

Group Type ACTIVE_COMPARATOR

Direct lateral approach

Intervention Type PROCEDURE

The hip joint is approached from laterally, and parts of the gluteus medius tendon is released from the greater trochanter before the hip joint is entered from the anterior side.

Spaire approach

Group Type EXPERIMENTAL

SPAIRE

Intervention Type PROCEDURE

The hip joint is entered from posterior, and the approach preserves the external rotators of the hip joint.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Direct lateral approach

The hip joint is approached from laterally, and parts of the gluteus medius tendon is released from the greater trochanter before the hip joint is entered from the anterior side.

Intervention Type PROCEDURE

SPAIRE

The hip joint is entered from posterior, and the approach preserves the external rotators of the hip joint.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Hardinge approach Muscle-sparing modification of the posterior approach

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Femoral neck fracture
* Clinical indication for hemiarthroplasty
* Age over 50 years

Exclusion Criteria

* Previous hip implants in the same hip
* Patients assessed to be in a terminal state with an expected survival of less than 1 week
* Other factors that makes follow-up impossible
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Oslo University Hospital

OTHER

Sponsor Role collaborator

University Hospital, Akershus

OTHER

Sponsor Role collaborator

Diakonhjemmet Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Siri Lillegraven, PhD

Role: STUDY_CHAIR

Diakonhjemmet Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Diakonhjemmet Hospital

Oslo, , Norway

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Norway

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Maren Paus, MD

Role: CONTACT

+4722454755

Mads Sundet, PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Maren Paus, MD

Role: primary

+4722454755

Mads Sundet, PhD

Role: backup

+4722451500

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HIFSAT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.